Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemental impurities of dioctahedral smectite (DWJ1230 vs DWB2001) in functional diarrhea and IBS-D
NCT05816681Phase 1Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Aug 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BioSponge in functional diarrhea and irritable bowel syndrome (IBS) (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoint: Concentration of lead in blood at Day 7. Started Aug 2022; status: completed.
02
Drugs
BioSponge
03
Conditions
functional diarrheairritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05816681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05816681.